According analysts’ predictions, GSK will register £1bn in sales for Pandermix in the fourth quarter and £180m from Relenza in the third and fourth quarters.
GSK will announced results on Wednesday, followed by AstraZeneca on Thursday.
--------------
http://www.nebusiness.co.uk/business-news/latest-business-news/gazette-business-news/2009/10/26/healthy-boost-from-swine-flu-vaccine-51140-25016605/